LAVA Therapeutics (LVTX) Institutional Ownership $1.08 0.00 (0.00%) As of 01/7/2025 04:00 PM Eastern Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for LAVA Therapeutics (NASDAQ:LVTX)Number ofInstitutional Buyers(last 12 months)3TotalInstitutional Inflows(last 12 months)$287.13KNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$385.18K Get LVTX Insider Trade Alerts Want to know when executives and insiders are buying or selling LAVA Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data LVTX Institutional Buying and Selling by Quarter Ad True Market InsidersHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 different coins that have returned over 100%... But today, Chris is now making the biggest crypto call of his ENTIRE career…#1 FREE Crypto for 2025 LAVA Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/20/2024Virtu Financial LLC19,103$32K0.0%N/A0.075% 11/15/2024Sphera Funds Management LTD.146,457$243K0.0%-60.2%0.000% 11/14/2024Walleye Capital LLC14,762$25K0.0%-42.5%0.000% 10/8/2024Pathway Financial Advisors LLC102,500$170K0.0%+70.8%0.404% 8/12/2024XTX Topco Ltd30,807$55K0.0%N/A0.122% 7/24/2024Pathway Financial Advisors LLC60,000$108K0.0%+328.6%0.000% Get the Latest News and Ratings for LVTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for LAVA Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 4/10/2024Pathway Financial Advisors LLC14,000$47K0.0%N/A0.000% 5/12/2023Bruce & Co. Inc.671,874$1.12M0.3%+571.9%2.650% 2/10/2023PNC Financial Services Group Inc.50,000$175K0.0%N/A0.197% 2/1/2023Bank of Montreal Can89,600$530K0.0%N/A0.353% 11/14/2022UBS Oconnor LLC75,000$343K0.0%N/A0.296% 10/28/2022Silverarc Capital Management LLC610,809$2.79M0.9%N/A2.409% 8/16/2022DAFNA Capital Management LLC128,335$379K0.1%-7.9%0.506% 8/15/2022Nantahala Capital Management LLC322,980$953K0.0%-3.3%1.274% 2/14/2022Point72 Asset Management L.P.119,152$655K0.0%-3.8%0.470% 11/15/2021Point72 Asset Management L.P.123,911$734K0.0%N/A0.489% 11/15/2021AXA S.A.229,121$1.36M0.0%+3.8%0.904% 11/12/2021Falcon Edge Capital LP140,229$830K0.1%-3.2%0.553% 8/17/2021Woodline Partners LP86,904$946K0.0%-23.3%0.343% 8/17/2021Millennium Management LLC138,831$1.51M0.0%-38.6%0.548% 8/16/2021Redmile Group LLC2,816,196$30.64M0.5%-0.3%11.108% 8/13/2021Geode Capital Management LLC12,997$141K0.0%N/A0.051% 8/11/2021Bank of New York Mellon Corp25,288$275K0.0%-26.3%0.100% 8/10/2021Nicholas Investment Partners LP781,867$8.51M0.5%-4.0%3.084% 8/2/2021New York State Common Retirement Fund19,136$208K0.0%-26.3%0.075% 5/27/2021Davidson Kempner Capital Management LP2,000$30K0.0%N/A0.008% 5/18/2021Millennium Management LLC226,205$3.44M0.0%N/A0.892% 5/18/2021Point72 Asset Management L.P.5,561$84K0.0%N/A0.022% 5/18/2021Tudor Investment Corp Et Al19,614$298K0.0%N/A0.077% 5/18/2021Redmile Group LLC2,824,409$42.90M0.6%N/A11.141% 5/18/2021Davidson Kempner Capital Management LP2,000$30K0.0%N/A0.008% 5/18/2021Citadel Advisors LLC60,442$918K0.0%N/A0.238% 5/18/2021Falcon Edge Capital LP150,454$2.29M0.1%N/A0.593% 5/17/2021Point72 Hong Kong Ltd9,355$142K0.0%N/A0.037% 5/17/2021Woodline Partners LP113,242$1.72M0.0%N/A0.447% 5/17/2021Caas Capital Management LP30,000$456K0.0%N/A0.118% 5/17/2021Pinz Capital Management LP25,900$393K0.1%N/A0.102% 5/17/2021Sphera Funds Management LTD.213,894$3.25M0.2%N/A0.844% 5/17/2021Novo Holdings A S3,327,312$50.54M2.1%N/A13.124% 5/14/2021Nantahala Capital Management LLC381,227$5.79M0.2%N/A1.504% Elon Musk’s FINAL Move (Ad)I call it "Elon's Final Move" because his new AI venture will dominate Tesla...Get all the details here >>>5/14/2021Nicholas Investment Partners LP814,840$12.38M0.9%N/A3.214% 5/14/2021Monashee Investment Management LLC265,000$3.02M0.5%N/A1.045% 5/13/2021Bank of New York Mellon Corp34,319$521K0.0%N/A0.135% 5/12/2021Pura Vida Investments LLC54,000$820K0.0%N/A0.213% (Data available from 1/1/2016 forward) LVTX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of LVTX shares? During the previous two years, the following institutional investors and hedge funds held shares of LAVA Therapeutics shares: Bruce & Co. Inc. ($1.12M), Bank of Montreal Can ($530K), Sphera Funds Management LTD. ($243K), PNC Financial Services Group Inc. ($175K), Pathway Financial Advisors LLC ($170K), XTX Topco Ltd ($55K), and Virtu Financial LLC ($32K).Learn more on LVTX's institutional investors. Which institutional investors have been buying LAVA Therapeutics stock? The following institutional investors have purchased LAVA Therapeutics stock in the last 24 months: Bruce & Co. Inc. ($571.87K), Pathway Financial Advisors LLC ($102.50K), Bank of Montreal Can ($89.60K), PNC Financial Services Group Inc. ($50K), XTX Topco Ltd ($30.81K), and Virtu Financial LLC ($19.10K). How much institutional buying is happening at LAVA Therapeutics? Institutional investors have bought a total of 863,884 shares in the last 24 months. This purchase volume represents approximately $1.73M in transactions. Which LAVA Therapeutics major shareholders have been selling company stock? The following institutional investors have sold LAVA Therapeutics stock in the last 24 months: Sphera Funds Management LTD. ($221.13K), and Walleye Capital LLC ($10.91K). How much institutional selling is happening at LAVA Therapeutics? Institutional investors have sold a total of 232,038 shares in the last 24 months. This volume of shares sold represents approximately $385.18K in transactions. Related Companies OS Therapies Major Shareholders Nuvectis Pharma Major Shareholders Editas Medicine Major Shareholders Adverum Biotechnologies Major Shareholders Coya Therapeutics Major Shareholders Applied Therapeutics Major Shareholders Oramed Pharmaceuticals Major Shareholders Immunic Major Shareholders Pyxis Oncology Major Shareholders PowerUp Acquisition Major Shareholders This page (NASDAQ:LVTX) was last updated on 1/8/2025 by MarketBeat.com Staff From Our PartnersDeFi Coin on Verge of Breakout!The blueprint for millionaires is here. Don't let this be the missed opportunity you regret for years. Crypto 101 Media | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | Sponsored#1 Crypto of 2025Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredDonald Trump to Repeal Executive Order #14110?Nvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LAVA Therapeutics Please log in to your account or sign up in order to add this asset to your watchlist. Share LAVA Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
